The Association of the British Pharmaceutical Industry (ABPI) has said that the new 10-year plan for the NHS has underplayed …
Health Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
The Association of the British Pharmaceutical Industry (ABPI) has said that the new 10-year plan for the NHS has underplayed …
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Despite worried …
Madrigal Pharma could be just weeks away from becoming the first drugmaker to claim EU approval for a treatment for …
Listen to the article 8 min This audio is auto-generated. Please let us know if you have feedback. Welcome to …
The combination of Bayer’s mineralocorticoid receptor antagonist (MRA) finerenone and Boehringer Ingelheim and Eli Lilly’s SGLT2 inhibitor Jardiance works better …
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Antibody-drug conjugates …
Roche’s Itovebi was the first PI3K inhibitor to get approved as a first-line treatment for breast cancer last year – …
Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Diagnostics companies …
The challenges facing biotechs amid the ongoing financial fallout have resulted in the winding down of one US biotech, Vor …
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. The days …
Health-Newswire.Net™ aggregates, publishes and distributed news about the Healthcare industry. In association with EmailWire, Health-Newswire.Net™ provides press release distribution services in the Healthcare sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:
Health Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC